Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.70p
   
  • Change Today:
    -0.040p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 1,849,652
  • Market Cap: £13.49m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £40,188
Lisa Baderoon 583,963 £15,767
Tim Franklin 525,000 £14,175

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 64,932,129 £1,753,168
Luca & Associates AG 22,000,000 £594,000
Invesco Ltd 17,872,341 £482,553
Aviva Investors Global 11,285,180 £304,700
Alora Pharmaceuticals LLC 10,909,091 £294,546
M&G Investments 7,600,000 £205,200
Prudential plc 7,600,000 £205,200
Capital Income Builder 4,870,367 £131,500
Dr R Zimmer 4,551,553 £122,892
Odey Asset Management 3,433,319 £92,700
Rhone Trustees (Switzerland) SA 3,386,000 £91,422
Pictet Overseas Trust Corporation Limited 3,287,500 £88,762

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.70p
Change Today -0.040p
% Change -1.46 %
52 Week High 5.90
52 Week Low 1.09
Volume 1,849,652
Shares Issued 499.72m
Market Cap £13.49m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.7% below the market average28.7% below the market average28.7% below the market average28.7% below the market average28.7% below the market average
14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average
Price Trend
65.50% above the market average65.50% above the market average65.50% above the market average65.50% above the market average65.50% above the market average
87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 28-May-2025

Time Volume / Share Price
16:28 132 @ 2.65p
15:50 110,000 @ 2.67p
15:07 20,000 @ 2.67p
15:01 3,619 @ 2.76p
14:57 100,000 @ 2.70p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page